Emalex Biosciences logo

Emalex Biosciences Employee Directory

Biotechnology ResearchIllinois, United States51-200 Employees

Emalex Biosciences is a Chicago-based biotechnology company focused on developing therapies for central nervous system disorders, with a late-stage program aimed at Tourette syndrome and other neurological conditions. The company was founded in 2018 when Paragon Biosciences established it to pursue novel CNS treatments, and it operates with a mid-sized team in the biotechnology research sector. Its activities center on advancing drug candidates through late-stage development to address unmet needs in neurology.

Its lead asset, ecopipam, targets the D1 receptor pathway associated with tic expression and is being developed for Tourette syndrome. In 2026, Teva Pharmaceutical Industries completed the acquisition of Emalex Biosciences, a move described as strengthening Teva's late-stage pipeline with ecopipam.

Find Emalex Biosciences employees' phone numbers or email addresses

Emalex Biosciences Global Highlights

Location
Employees

North America
47

Minus sign iconPlus sign icon
  • United States Of America
    46
  • Canada
    1

Asia
1

Minus sign iconPlus sign icon
  • Indonesia
    1

Emalex Biosciences's Leadership

  • Stylized image of a person
    G. K.
    Vice President Of Medical Affairs
    Phone icon
  • Stylized image of a person
    J. W.
    Vice President, Chemistry, Manufacturing & Controls
    Phone icon
  • Stylized image of a person
    C. W.
    Sr. Director, Drug Product Development
    Phone icon

Emalex Biosciences Employee Metrics

100%
50%
0%
2026
2025
  • Quality Assurance
  • Sales
  • Accounting
  • Legal
  • Product Management
  • Other

Contact profiles from Emalex Biosciences

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    G. K.
    Vice President Of Medical Affairs
    Phone icon
    Jul 14, 2026
  • Stylized image of a person
    J. W.
    Vice President, Chemistry, Manufacturing & Controls
    Phone icon
    CanadaOntario
    Jul 07, 2026
  • Stylized image of a person
    C. W.
    Sr. Director, Drug Product Development
    Phone icon
    Jun 23, 2026

Frequently Asked Questions

What is Emalex Biosciences known for?

Minus sign iconPlus sign icon
Emalex Biosciences was founded in 2018 operates in the Biotechnology Research industry. Explore Emalex Biosciences's company overview page for more information.

What is Emalex Biosciences's most common email format?

Minus sign iconPlus sign icon
Emalex Biosciences employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Emalex Biosciences email formats with LeadIQ.

How many employees does Emalex Biosciences have currently?

Minus sign iconPlus sign icon
Emalex Biosciences has approximately 54 employees as of July 2026. These team members are located across 2 continents, including North AmericaAsia.

Who are Emalex Biosciences's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Emalex Biosciences's key employees include:

  • Vice President Of Medical Affairs: G. K.
  • Vice President, Chemistry, Manufacturing & Controls: J. W.
  • Sr. Director, Drug Product Development: C. W.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.